A small-scale method of sample preparation suitable for simultaneous HPLC-UV assay of capecitabine and its 5’-DFCR metabolite in mouse blood plasma
DOI:
https://doi.org/10.1590/s2175-97902022e201043Keywords:
Capecitabine, 5′-deoxy-5-fluorocytidine, Mouse blood plasma, Sample preparation, HPLCAbstract
The objective of the study was to develop an easy, cheap, effective, and safe, small-scale method for sample preparation suitable for the simultaneous high-performance liquid chromatography (HPLC)-ultraviolet (UV) assay of capecitabine and its 5′-deoxy-5-fluorocytidine (5′-DFCR) metabolite in mouse blood plasma. The suitability of the proposed method of sample preparation was verified by the optimal effectiveness and efficiency achieved in the overall analytical workflow. The chromatographic separation of capecitabine and its first metabolite was performed on a Hypersil GOLD aQ column with a mobile phase consisting of 1% formic acid, methanol, and water, and run in a gradient elution mode. The absence of interfering endogenous components at the retention times of each analyte was confirmed by the chromatographic analysis of blank matrices and matrices spiked with the corresponding standards. The absence of any tactile matrix effect was also recorded. For the first time, the effect of the vacutainer’s anticoagulant on the extraction efficiency of both analytes was evaluated. The method was found to be accurate, precise, and specific. The estimated mean “extraction” efficiencies were ≥90% for each analyte. The lower limit of quantitation for both capecitabine and 5′-DFCR was 0.05 μg/mL.
Downloads
References
Abdulra’uf LB, Sirhan AY, Huat Tan G. Recent developments and applications of liquid phase microextraction in fruits and vegetables analysis. J Sep Sci. 2012;35(24):3540-3553.
Alshammari TM, Al-Hassan AA, Hadda TB, Aljofan M. Comparison of different serum sample extraction methods and their suitability for mass spectrometry analysis. SPJ. 2015;23(6):689-697.
Avendaño C, Menéndez CJ. Antimetabolites That Interfere with Nucleic Acid Biosynthesis. In: Avendaño C, Menéndez CJ, editors. Medicinal Chemistry of Anticancer Drugs. 2nd ed. Elsevier; 2015. p. 23-79.
Budman DR, Meropol NJ, Reigner B, Creaven PJ, Lichtman SM, Berghorn E, et al. Preliminary studies of a novel oral fluoropyrimidine carbamate: Capecitabine. J Clin Oncol. 1998;16(5):1795-1802.
Dhananjeyan MR, Liu J, Bykowski C, Trendel JA, Sarver JG, Ando H, et al. Rapid and simultaneous determination of capecitabine and its metabolites in mouse plasma, mouse serum, and in rabbit bile by high-performance liquid chromatography. J Chromatogr A. 2007;1138(1-2):101-108.
Eurachem Guide: The Fitness for Purpose of Analytical Methods. [cited 2020 Oct 26]. Available from: Available from: https://www.eurachem.org/images/stories/Guides/pdf/MV_guide_2nd_ed_EN.pdf
» https://www.eurachem.org/images/stories/Guides/pdf/MV_guide_2nd_ed_EN.pdf
Farkouh A, Ettlinger D, Schueller J, Georgopoulos A, Scheithauer W, Czejka MA. Rapid and Simple HPLC Assay for Quantification of Capecitabine for Drug Monitoring Purposes. Anticancer Res. 2010;30(12):5207-5211.
Hassanlou S, Rajabi M, Shahrasbi A, Afshar M. Development and Validation of an Ecofriendly HPLC-UV Method for Determination of Capecitabine in Human Plasma: Application to Pharmacokinetic Studies. S Afr J Chem. 2016;69:174-179.
Jayaseelan S, Bajivali S, Ramesh U, Sekar V, Perumal P. Bioanalytical Method Development and Validation of Capecitabine by RP-HPLC Method. Int J Chemtech Res. 2010;2(4):2086-2090.
Komarov T, Medvedev Y, Ramenskaya G, Shohin I, Yarushok T, Midruev E. Method development and validation for determination of anticancer drug capecitabine and its active metabolite 5-fluoruracil in human plasma for PK studies. Russ J Biopharm. 2014;6(5):62-67. https://submit.biopharmj. ru/ojs238/index.php/biopharmj/issue/view/34/showToc
» https://submit.biopharmj. ru/ojs238/index.php/biopharmj/issue/view/34/showToc
Mena-Bravo A, Priego-Capote F, Luque de Castro MD. Study of blood collection and sample preparation for analysis of vitamin D and its metabolites by liquid chromatography- tandem mass spectrometry. Anal Chim Acta. 2015;879:69-76.
Moldoveanu SC. Solutions and Challenges in Sample Preparation for Chromatography. J Chromatogr Sci. 2004;42(1):1-14.
Moldoveanu S, David V. Preliminaries to Sample Preparation. In: Moldoveanu S, David V, editors. Modern Sample Preparation for Chromatography. Elsevier Inc; 2015. p. 3-32.
Murphy F, Middleton М. Cytostatic and cytotoxic drugs. In: Aronson JK, editor. Side Effects of Drugs Annual. Elsevier; 2012. p. 731-747.
Onodera H, Kuruma I, Ishitsuka H, Horii I. Pharmacokinetic Study of Capecitabine in Monkeys and Mice; Species Differences in Distribution of the Enzymes Responsible for its Activation to 5-FU. Drug Metab Pharmacokinet. 2000;15(5):439-451.
Piórkowska E, Kaza M, Fitatiuk J, Szlaska I, Pawiński T, Rudzki PJ. Rapid and simplified HPLC-UV method with on-line wavelengths switching for determination of Capecitabine in human plasma. Pharmazie. 2014;69(7):500-505.
Shi RZ, Rossum HH, Bowen RR. Serum testosterone quantitation by liquid chromatography-tandem mass spectrometry: Interference from blood collection tubes. Clin Biochem. 2012;45(18):1706-1709.
Stargel WW, Roe CR, Routledge PA, Shand DG. Importance of blood-collection tubes in plasma lidocaine determinations. Clin Chem. 1979;25(4):617-619.
Švobaitė R, Solassol I, Pinguet F, Mazard T, Ivanauskas L, Ychou M, et al. A liquid chromatography-mass spectrometry method for the simultaneous determination of Capecitabine, 5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, 5-fluorouracil, and 5-fluorodihydrouracil in human plasma. J Liq Chromatogr Relat Technol. 2010;33(19):1705-1719.
Thorat S, Chikhale R, Tajne M. Development and Validation of HPLC and HPTLC Methods for Therapeutic Drug Monitoring of Capecitabine in Colorectal Cancer Patients. Journal of Chromatographic Science. J Chromatogr Sci . 2019;57(10):892-900.
Toennes SW, Kauert GF. Importance of Vacutainer Selection in Forensic Toxicological Analysis of Drugs of Abuse. J Anal Toxicol. 2001;25(5):339-343.
Vijaya Jyothi M, Bhargav E, Keerthana B, Varalakshmi D. RP-HPLC method development and validation for the simultaneous estimation of irinotecan hydrochloride and capecitabine in active pharmaceutical ingredients (APIs). Int J Pharm Sci Res. 2018;9(1):63-67.
Wang W, Liu J, Han Y, Huang W, Wang Q. The most convenient and general approach for plasma sample clean- up: multifunction adsorption and supported liquid extraction. Bioanalysis. 2012;4(3):223-225.
Wang Z, Li X, Yang G, Zhang F, Li M, Chen W, et al. Sensitive and Efficient Method for Determination of Capecitabine and Its Five Metabolites in Human Plasma Based on One-Step Liquid-Liquid Extraction. J Anal Methods Chem. 2019;8:1-10.
Zufı́a L, Aldaz A, Giráldez J. Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection. J Chromatogr B. 2004;809(1):51-58.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
